Conference: ARVO 2025

Comparison of Myopia Progression in Individuals Wearing Defocus Incorporated Multiple Segments (DIMS) Spectacle Lenses for Eight Years versus Shorter Durations

Leung et al.

 

Atropine And Spectacle Lens Combination Treatment (ASPECT): 12-Month Results Of A Randomised Controlled Trial For Myopia Control Using A Combination Of Defocus Incorporated Multiple Segments (DIMS) Lenses And 0.025% Atropine

Villahoz-Guemes et al.

Efficacy of Defocus Incorporated Multiple Segments (DIMS) Lenses in Retarding Myopic Shifts Among Pre-Myopic Preschoolers: Nine-Month Results of a Pilot Study

Yang et al.

Vision-Related Quality Of Life In Myopic Children Using Combination Treatment With Atropine And DIMS (Defocus Incorporated Multiple Segments) Spectacle Lenses: 12-Month Results

 Hernandez et al.

Evaluation of the Visual Performance of Two Modified Defocus Incorporated Multiple Segments (DIMS) Spectacle Lens Designs

Lam et al.

Prevalence of Amblyogenic Risk Factors in Young Scottish Children, and Variations Across Quintiles of Deprivation – Implications for Vision Screening Programmes

Evans et al.

Short-Term Effect Of Second-Generation Defocus Incorporated Multiple Segments Spectacle Lenses On Choroidal Thickness In Children

Chun et al.

Prevalence Of Amblyogenic Risk Factors In Young Scottish Children, And Variations Across Quintiles Of Deprivation – Implications For Vision Screening Programmes

Evans et al.

Disclaimer: MiYOSMART spectacle lenses have not been approved for use in myopia management in all countries, including the U.S., and are not currently available for sale in all countries, including the U.S